How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Close this folder7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
View the documentProduction of the paper-based formulary
View the documentFinal editing and layout of manuscript
Open this folder and view contentsUtilizing the electronic version of the WHO model formulary
View the documentElectronic publishing and distribution of the national formulary
View the documentImplementation to gain acceptance and credibility for the national formulary
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Implementation to gain acceptance and credibility for the national formulary

The process of implementation will be important for the rapid acceptance and use of information contained in the NF. Unless users are aware of, and know how to access and use the NF, the desired impact on rational use of medicines may not achieved. Several methods may be employed or combined to promote the use of the NF including:

- organization of an official launch supported by respected authorities including the Ministry of Health, professional societies (e.g. medical and pharmaceutical) and coverage by the media;

- placing advertisements, articles and interviews about the NF in national professional journals and the media;

- circulars, letters and posters sent out to health institutions and involving opinion leaders in the launching of the NF; and

- integrating dissemination of information about the NF with dissemination of other health policy, clinical guidelines or protocols.


These efforts should not be made only for the initial introduction of the NF, but some of them should be continued to raise wider awareness of the purpose and use of the NF.

The above recommendations are intended to point out basic essential tasks in the final production stage and do not attempt to give advice on professional book publishing. Various organizations provide support and training for publishers in developing countries; a comprehensive list of links to these organizations can be found on the Links page of the INASP’s web site.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014